SONIA N RUPP
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Child & Adolescent Psychiatry
- Where
- STATELINE, NV
- NPI
- 1548486699
- Received
- $1,461 in 68 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 22 | $446 |
| 2024 | General payment | 16 | $460 |
| 2023 | General payment | 9 | $183 |
| 2022 | General payment | 7 | $133 |
| 2021 | General payment | 5 | $93 |
| 2020 | General payment | 4 | $63 |
| 2019 | General payment | 5 | $80 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 11 | $257 | 2023–2025 |
| Janssen Pharmaceuticals, Inc | 5 | $205 | 2024 |
| Otsuka America Pharmaceutical, Inc. | 10 | $187 | 2019–2025 |
| Lundbeck LLC | 7 | $119 | 2019–2024 |
| Supernus Pharmaceuticals, Inc. | 6 | $106 | 2021–2025 |
| Vanda Pharmaceuticals Inc. | 4 | $79 | 2024–2025 |
| Alkermes, Inc. | 3 | $77 | 2024–2025 |
| Indivior Inc. | 3 | $59 | 2023–2025 |
| Neurocrine BioSciences, Inc. | 3 | $58 | 2022–2025 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 | 2025 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 | 2025 |
| Alfasigma USA, Inc. | 3 | $51 | 2020–2022 |
| IRONSHORE PHARMACEUTICALS INC. | 2 | $49 | 2022 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 | 2024 |
| Axsome Therapeutics, Inc. | 1 | $25 | 2023 |
| Collegium Pharmaceutical, Inc. | 1 | $18 | 2025 |
| Shire North American Group Inc | 1 | $14 | 2019 |
| Tris Pharma Inc | 1 | $13 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 68 | $1,461 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-05 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-29 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-23 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-01 | Supernus Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-09-18 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-27 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-20 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-13 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-09 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-12 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-04 | Indivior Inc. | $18 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-05-20 | Supernus Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-05-13 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-07 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-24 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-02-26 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-05 | Collegium Pharmaceutical, Inc. | $18 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-02-05 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-14 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2024-12-11 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-12-05 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-20 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-10-23 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-11 | Janssen Pharmaceuticals, Inc | $31 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-20 | Vanda Pharmaceuticals Inc. | $28 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-08-08 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-07 | Janssen Pharmaceuticals, Inc | $22 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-07-09 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-06-17 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-04-11 | Janssen Pharmaceuticals, Inc | $128 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-04-11 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-04-10 | Indivior Inc. | $17 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2024 | |
| 2024-03-13 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-18 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-09-21 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-24 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-08-17 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-04 | Supernus Pharmaceuticals, Inc. | $14 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-07-18 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-06-20 | Indivior Inc. | $24 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-05-25 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-23 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-02-21 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2022-11-15 | IRONSHORE PHARMACEUTICALS INC. | $36 | Food and Beverage | In-kind items and services | JORNAY PM Drug, Central Nervous Stimulant ADHD | 2022 | |
| 2022-10-26 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-09-15 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-06-16 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-05-23 | Alfasigma USA, Inc. | $15 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-04-14 | Supernus Pharmaceuticals, Inc. | $12 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-03-15 | IRONSHORE PHARMACEUTICALS INC. | $13 | Food and Beverage | In-kind items and services | JORNAY PM Drug, Central Nervous Stimulant ADHD | 2022 | |
| 2021-12-15 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-10-26 | Supernus Pharmaceuticals, Inc. | $25 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2021 | |
| 2021-10-21 | Alfasigma USA, Inc. | $16 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-07-29 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-05-25 | Lundbeck LLC | $22 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2021 | |
| 2020-09-15 | Lundbeck LLC | $11 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2020 | |
| 2020-06-02 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2020 | |
| 2020-01-28 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2020 | |
| 2020-01-13 | Alfasigma USA, Inc. | $19 | Food and Beverage | In-kind items and services | 2020 | ||
| 2019-07-17 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2019 | |
| 2019-07-09 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-04-25 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2019 | |
| 2019-04-03 | Tris Pharma Inc | $13 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2019 | |
| 2019-01-16 | Shire North American Group Inc | $14 | Food and Beverage | In-kind items and services | VYVANSE Drug, NEUROSCIENCE | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Stateline, NV, county Douglas County, NV, state Nevada; placed by its city name.
| Measure | Place (city or town) Stateline, NV | County Douglas County, NV | State Nevada |
|---|---|---|---|
| Population B01003 | 503 | 49,623 | 3,184,612 |
| Population, 2020 census P1 | 595 | 49,488 | 3,104,614 |
| Median age B01002 | 35.0 | 55.0 | 39.1 |
| Under 18 B01001 | 5.8% | 14.9% | 21.7% |
| 65 and over B01001 | 5.4% | 32.7% | 17.0% |
| Households B11001 | 249 | 21,325 | 1,202,593 |
| Foreign born B05002 | 25.4% | 6.2% | 19.1% |
| Median household income B19013 | $47,054 | $90,754 | $78,260 |
| Median family income B19113 | $60,571 | $105,745 | $92,663 |
| Per capita income B19301 | $38,892 | $59,360 | $41,354 |
| Poverty rate B17001 | 16.5% | 9.0% | 12.4% |
| Unemployment rate B23025 | 4.0% | 3.0% | 7.0% |
| Civilian labor force B23025 | 349 | 21,791 | 1,612,158 |
| Mean commute (minutes) B08013 | 8.4 | 26.2 | 24.8 |
| Bachelor's degree or higher B15003 | 20.5% | 31.6% | 27.9% |
| Housing units B25001 | 292 | 24,825 | 1,326,471 |
| Owner-occupied B25003 | 8.0% | 78.8% | 60.0% |
| Renters B25003 | 92.0% | 21.2% | 40.0% |
| Median home value B25077 | $-666,666,666 | $615,400 | $435,400 |
| Median gross rent B25064 | $1,750 | $1,593 | $1,597 |
| White, not Hispanic B03002 | 34.2% | 77.2% | 44.8% |
| Black B03002 | 0.0% | 0.3% | 9.0% |
| Hispanic or Latino B03002 | 55.3% | 13.0% | 29.6% |
| Asian B03002 | 7.8% | 2.3% | 8.8% |
| American Indian and Alaska Native B03002 | 0.0% | 1.1% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Stateline, NV.
Comments